fbpx
() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

News

Organigram Announces Letter of Intent for Strategic Investment in Hyasynth Biologicals Inc.

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQB: OGRMF) ("Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has entered into a letter of intent with Hyasynth Biologicals, Inc. ("Hyasynth") whereby Organigram proposes to make a strategic investment in Hyasynth.  Additionally, the non-binding letter of intent contemplates Organigram entering into an off-take agreement with Hyasynth whereby Organigram can purchase a pre-defined quantity of a range of cannabinoids or cannabinoid related production from Hyasynth on terms set forth in such agreement.
Read more
Get $50 in free trades.